What is the catalog number for Anti-Hu CD154 Pacific Blue™?

The catalog number for Anti-Hu CD154 Pacific Blue™ is PB-781-T100.

What sizes are available for Anti-Hu CD154 Pacific Blue™?

Anti-Hu CD154 Pacific Blue™ is available in the following size(s): 100 Tests.

Is Anti-Hu CD154 Pacific Blue™ in stock?

Anti-Hu CD154 Pacific Blue™ is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Anti-Hu CD154 Pacific Blue™?

Anti-Hu CD154 Pacific Blue™ is manufactured by AFG-XBO.

What is the estimated delivery time for Anti-Hu CD154 Pacific Blue™?

Estimated delivery time for Anti-Hu CD154 Pacific Blue™ is approximately 10 business day(s), depending on your location.

Anti-Hu CD154 Pacific Blue™

CD154 / CD40L (CD40 ligand) is a member of the tumor necrosis factor family, and is expressed primarily on activated CD4+ lymphocytes, but also on mast cells, basophils, eosinophils and human dendritic cells. Its counter-receptor CD40 is expressed on antigen presenting cells, including dendritic cells, macrophages, and B cells, and also on fibroblasts. Triggering of CD40 by CD40L causes maturation of dendritic cells and upregulation of antigen presentation in functions of the MHC and costimulatory molecules. CD40L also functions as a direct stimulating factor for T cells. CD40L plays also roles e.g. in antibody class switching and modulation of apoptosis in the germinal center.

Product Specifications

Certification

RUO

Reactivity

Human, Non-human primates

Immunogen

Human CD154 fusion protein

Target Antigen

CD154

Clone

24-31

Applications

FC (QC tested)

Format

Pacific Blue

Buffer

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

References & Citations

*Brams P, Black A, Padlan EA, Hariharan K, Leonard J, Chambers-Slater K, Noelle RJ, Newman R: A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation. Int Immunopharmacol. 2001 Feb;1 (2) :277-94., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=brams+p+black+a+padlan+ea , *Berner B, Wolf G, Hummel KM, Müller GA, Reuss-Borst MA: Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis. 2000 Mar;59 (3) :190-5., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=berner+b+wolf+g , *Barnhart B, Ford GS, Bhushan A, Song C, Covey LR: A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions. Immunology. 2000 Jan;99 (1) :54-61., URL: http://www.ncbi.nlm.nih.gov/pubmed/10651941 , *Kornbluth RS, Kee K, Richman DD: CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc Natl Acad Sci U S A. 1998 Apr 28;95 (9) :5205-10., URL: http://www.ncbi.nlm.nih.gov/pubmed/9560254 , *Grammer AC, McFarland RD, Heaney J, Darnell BF, Lipsky PE: Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol. 1999 Oct 15;163 (8) :4150-9., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=grammer+ac+heaney+j , *Fernandes MS, Gomes EM, Butcher LD, Hernandez-Alcoceba R, Chang D, Kansopon J, Newman J, Stone MJ, Tong AW: Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene. Clin Cancer Res. 2009 Aug 1;15 (15) :4847-56., URL: https://pubmed.ncbi.nlm.nih.gov/19622582/, *Kum WW, Hung RW, Cameron SB, Chow AW: Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1. J Infect Dis. 2002 Feb 15;185 (4) :555-60, URL: http://www.ncbi.nlm.nih.gov/pubmed/11865410

Storage Conditions

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Specificity

The mouse monoclonal antibody 24-31 detects an extracellular epitope of CD154 / CD40L (CD40-ligand), a 39 kDa cell surface type II glycoprotein expressed predominantly on activated CD4+ lymphocytes.